Philip Morton
Chief Technology Officer • Albumedix
Philip Morton has a strong technology background with over 25 years of experience in the biopharmaceutical industry, working across process and product development, and product application research. As the Chief Technology Officer of Albumedix, Dr Morton leads a team of specialists to refine recombinant albumin technologies and harness the multifaceted protein that is albumin.
Also speaking
Event Info
Sample Attendee List – 2024
Download and explore the 2024 Floorplan for Advanced Therapies Europe here.
3 December 2024
Enquire to Sponsor/Exhibit
Take a look at the sample attendee list for Advanced Therapies Europe 2024 here.
27 November 2024
